https://biotechmorning.com/news/illumina-shrinking-again-sequencing-industry-pressure Biotech Morning en 2026-06-14T14:22:32.317Z Illumina Is Shrinking Again. The Reason Why Should Worry Every Sequencing Company. https://biotechmorning.com/news/jj-myeloma-talvey-darzalex-combo-eha-2026 Biotech Morning en 2026-06-14T14:21:37.777Z J&J Wants to Own Every Line of Myeloma Treatment. It Might Be Working. https://biotechmorning.com/news/survodutide-visceral-liver-fat-obesity-drug Biotech Morning en 2026-06-14T14:20:42.160Z The Obesity Drug That Doesn't Care About Your Scale https://biotechmorning.com/news/obesity-drug-makes-surgery-look-like-warmup Biotech Morning en 2026-06-14T14:19:51.090Z The Obesity Drug That Makes Surgery Look Like a Warm-Up https://biotechmorning.com/news/biotech-biggest-ipo-week-2026 Biotech Morning en 2026-06-14T14:18:53.973Z Biotech's IPO Market Roars Back to Life https://biotechmorning.com/news/novartis-avidity-rna-muscular-dystrophy-data Biotech Morning en 2026-06-14T14:17:51.952Z Novartis Just Dropped $12B on an RNA Bet. The First Report Card Is In. https://biotechmorning.com/news/lilly-ajax-jak2-inhibitor-early-data Biotech Morning en 2026-06-14T14:16:59.485Z Lilly Spent $2.3B on a Drug Nobody Had Tested in Humans. It Might Already Be Working. https://biotechmorning.com/news/prostate-cancer-pten-her2-moment-truqap Biotech Morning en 2026-06-14T14:16:09.991Z Prostate Cancer Just Got Its HER2 Moment https://biotechmorning.com/news/incyte-genesis-ai-drug-discovery-expansion Biotech Morning en 2026-06-14T14:15:16.491Z Incyte Just Bet $120M That an AI Can Out-Design Its Own Chemists https://biotechmorning.com/news/summit-therapeutics-500m-offering-canceled Biotech Morning en 2026-06-13T14:24:31.070Z Summit Therapeutics Tried to Raise $500M. It Lasted One Day. https://biotechmorning.com/news/glp1-pregnancy-exposure-harvard-study Biotech Morning en 2026-06-13T14:23:42.764Z Millions of Women Take Ozempic. What Happens If They Get Pregnant? https://biotechmorning.com/news/whoop-fda-blood-pressure-fight Biotech Morning en 2026-06-13T14:22:53.242Z Whoop Just Picked a Fight With the FDA. It Might Not Win. https://biotechmorning.com/news/amgen-tavneos-fda-withdrawal-duke-review Biotech Morning en 2026-06-13T14:21:59.544Z Amgen's $3.7 Billion Drug Is About to Face a Jury of Scientists https://biotechmorning.com/news/wegovy-oral-pill-uk-mhra-approval Biotech Morning en 2026-06-13T14:21:09.459Z Wegovy Just Ditched the Needle in the UK https://biotechmorning.com/news/cms-locks-in-medicare-drug-price-negotiations Biotech Morning en 2026-06-13T14:20:22.748Z CMS Just Made Big Pharma's Worst Nightmare Harder to Wake Up From https://biotechmorning.com/news/roche-nurix-btk-degrader-bexobrutideg-deal Biotech Morning en 2026-06-13T14:19:25.588Z Roche Just Paid $700M Upfront for a Drug That Destroys Its Target https://biotechmorning.com/news/lilly-retatrutide-sleep-apnea-phase-3 Biotech Morning en 2026-06-13T14:18:29.866Z Lilly's Next Obesity Drug Might Kill Your CPAP Machine https://biotechmorning.com/news/roche-enicepatide-obesity-weight-loss-trial Biotech Morning en 2026-06-13T14:17:41.467Z Roche Just Crashed the Obesity Party With a Number Nobody Expected https://biotechmorning.com/news/fda-war-cheap-ozempic-knockoffs Biotech Morning en 2026-06-13T14:16:50.643Z The FDA Just Declared War on Cheap Ozempic Knockoffs